---
title: "Apeloa Pharmaceutical's Unit Gets Registration Certificate for Cefdinir Capsules"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/266849866.md"
description: "Apeloa Pharmaceutical's Unit Gets Registration Certificate for Cefdinir Capsules"
datetime: "2025-11-21T04:32:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266849866.md)
  - [en](https://longbridge.com/en/news/266849866.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266849866.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/266849866.md) | [English](https://longbridge.com/en/news/266849866.md)


# Apeloa Pharmaceutical's Unit Gets Registration Certificate for Cefdinir Capsules



### 相關股票

- [APELOA (000739.CN)](https://longbridge.com/zh-HK/quote/000739.CN.md)

## 相關資訊與研究

- [Apeloa Pharmaceutical Subsidiary Gets China Approval for Antibiotics](https://longbridge.com/zh-HK/news/268186949.md)
- [Apeloa Pharmaceutical Obtains Drug Registration for Levocarnitine Injection](https://longbridge.com/zh-HK/news/263996571.md)
- [BREAKINGVIEWS-Donald Trump’s biggest trade shock is yet to come: podcast](https://longbridge.com/zh-HK/news/278498422.md)
- [Lonza Agrees CHF2.3 Billion Sale of Capsules, Ingredients Business to Conclude Transformation Plan](https://longbridge.com/zh-HK/news/278325835.md)
- [RFK Jr. losing battle to boost trust in public health agencies](https://longbridge.com/zh-HK/news/278369245.md)